What is the number of krait species found in India?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kraits in India: Species, Distribution, and Clinical Significance

There are 8-9 species of kraits (genus Bungarus) found in the Indian subcontinent, with Bungarus caeruleus (Common or Indian krait) and Bungarus niger being the most highly venomous species. 1

Species Distribution and Significance

  • The Indian subcontinent (including India, Bangladesh, Bhutan, Nepal, Pakistan, Sri Lanka, and Maldives) is home to 8-9 species of kraits 1
  • Kraits belong to the genus Bungarus and are part of the Elapidae family of venomous snakes 1
  • The Common krait (Bungarus caeruleus) and B. niger are considered the most highly venomous species among the kraits found in India 1
  • The Common krait is one of the "Big Four" venomous snakes responsible for the majority of snakebite deaths in India 2

Venom Characteristics and Clinical Significance

  • Common krait venom is predominantly composed of phospholipases A2 (64.5% of total proteins), with at least 4.6% being presynaptically-acting β-bungarotoxin A-chains 3
  • Three-finger toxins (19.0%) are the second most abundant components, including 15.6% κ-neurotoxins which are potent postsynaptically-acting long neurotoxins 3
  • Krait venom causes severe neurotoxicity that can lead to paralysis, respiratory failure, and death within a short time frame 3
  • The absence of cytotoxins in krait venom correlates with the lack of local envenoming signs (pain, swelling), making bites potentially insidious until paralysis sets in 3

Clinical Presentation of Krait Bites

  • Krait bites typically occur at night while victims are asleep on the floor 4
  • Cardinal symptoms include abdominal pain developing within hours of the bite 4
  • Altered consciousness is observed in 71% of patients (drowsiness, semiconsciousness, or deep coma) 4
  • Autonomic disturbances including transient hypertension, tachycardia, lacrimation, sweating, and salivation occur in 66% of patients with moderate to severe envenomation 4
  • Metabolic complications include hypokalaemia (71%) and metabolic acidosis (50%) 4
  • Neurological complications include anterograde memory loss (40%) and delayed neuropathy (22%) 4

Treatment and Management

  • Anti-snake venom (ASV) is the most specific therapy available for krait envenomation 5
  • The polyvalent antivenom produced in India is effective against envenomation by kraits and is used across the Indian subcontinent 5
  • High doses of ASV may be required for reversal of neurological manifestations in severe krait envenomation 5
  • Early access to mechanical ventilation is critical for reducing mortality in severe cases 4
  • Venom samples from Sri Lanka, India, and Pakistan show comparable profiles but variable immunoreactivities to available antivenoms 3

Prevention Strategies

  • Regular tick checks on humans and pets after spending time in tick-infested habitats can help prevent tick-borne diseases, which is a general principle that can be applied to snake habitats as well 6
  • Use of protective clothing when outdoors, including long-sleeved shirts, pants, socks, and closed-toe shoes can reduce exposure risk 6
  • Limiting exposure to snake-infested habitats, especially during nighttime when kraits are most active, is an important preventive measure 6, 4

Understanding the distribution, venom characteristics, and clinical presentation of krait bites is essential for proper management and prevention of envenomation in the Indian subcontinent.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.